Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

Use of remdesivir and/or nirmatrelvir/ritonavir in patients hospitalised for acute SARS-CoV-2 is tied to fewer deaths during ...

Egg based and non egg based flu vaccines were equally effective at preventing influenza like illness among healthy adults ...

Hologic’s FDA clearance for its Panther Fusion GI Bacterial and Expanded Bacterial Assays represents the company’s entry into the gastroenteritis test market.

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

At 12 months, risk factors for persistence of long COVID symptoms included male sex, fever, and taste disorder.

Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...

Cell culture-based inactivated influenza vaccine was effective among children and adults during the 2023 to 2024 season, particularly in young children.

The continually expanding toolkit from Mohit Verma’s laboratory at Purdue University now includes a portable paper-based ...